LCTX logo

Lineage Cell Therapeutics (LCTX) P/E Ratio

PE Ratio

N/A

27 min ago

LCTX PE Ratio Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LCTX PE Ratio Performance

PeriodPeriodPE ratioPE ratioPricePriceTTM EPSTTM EPSTTM revenueTTM revenue
todaytoday--7.4%+15.4%+41.0%
1 m1 month--0.9%--
3 m3 months--36.9%--
6 m6 months--37.6%--
ytdytd-+7.0%--
1 y1 year--56.6%+8.3%-2.5%
5 y5 years--26.9%-175.0%+489.9%

LCTX PE Ratio High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month
3 m3 months
6 m6 months
1 y1 year
3 y3 years
5 y5 years
alltimeall time18.572.13

Lineage Cell Therapeutics PE Ratio History

DateValue
DateValue
2016
11.28

FAQ

  • What is the all time high PE ratio for Lineage Cell Therapeutics?

What is the all time high PE ratio for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high price to earnings ratio is 18.57